Dr. Kevin D Malone, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1104 W Evergreen Ave, Effingham, IL 62401 Phone: 217-347-2500 Fax: 217-342-9775 |
Lisa A Kowalski, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 N Maple St, Effingham, IL 62401 Phone: 217-342-4151 Fax: 217-347-3033 |
Jason J Mcallaster, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 N Maple St, Effingham, IL 62401 Phone: 217-342-4151 Fax: 217-342-4190 |
Dr. Patrick Kyle Stewart, M.D. Surgery - Surgery of the Hand Medicare: Accepting Medicare Assignments Practice Location: 901 Medical Park Dr Ste 100, Effingham, IL 62401 Phone: 217-347-7400 |
Kevin A Calder, MD Surgery - Plastic and Reconstructive Surgery Medicare: Medicare Enrolled Practice Location: 900 W Temple Ave, Effingham, IL 62401 Phone: 217-540-2350 |
Dr. Mohammed Iyoob Mohammed Ilyas, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 904 Medical Park Dr Ste 2, Effingham, IL 62401 Phone: 217-347-2255 |
Dr. Ruben D Boyajian, MD Surgery Medicare: May Accept Medicare Assignments Practice Location: 900 West Temple Avenue, Building B - Suite 2500, Effingham, IL 62401 Phone: 217-347-2255 Fax: 217-342-6910 |
Dr. James J Flaig, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 1104 W Evergreen Ave, Effingham, IL 62401 Phone: 217-347-2500 Fax: 217-342-9775 |
News Archive
A new report published in the prestigious New England Journal of Medicine (NEJM) shows that patients treated with bronchial thermoplasty, the first non-drug treatment for asthma, demonstrated an overall improvement in asthma control.
The botanical extract honokiol, a biologically active molecule isolated from the bark of Magnolia spp., holds promise as an adjunct treatment for aggressive bladder and kidney cancers, as reported in two new studies. New research on honokiol in bladder cancer was presented at the American Association for Cancer Research Annual Meeting 2015.
A minimally invasive procedure known as endovascular repair used for abdominal aortic aneurysms has a low rate of complications, even in high-risk patients such as those with kidney, heart or lung problems, a Mayo Clinic study shows.
ImmunoGen, Inc., a biotechnology company, today announced the presentation of new clinical data for the investigational compound, SAR3419, at the American Society of Clinical Oncology (ASCO) annual meeting taking place in Chicago, IL.
› Verified 5 days ago